a Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses-Paris (CIMI-Paris), Assistance Publique-Hôpitaux de Paris (AP-HP), Groupement Hospitalier Pitié-Salpêtrière, , Département d'Immunologie , Paris , France.
b Department of Clinical Immunology , Université Paris Diderot Paris 7 , Paris , France.
Gut Microbes. 2019;10(3):429-433. doi: 10.1080/19490976.2018.1546520. Epub 2018 Nov 18.
In a recently published article we report the metagenomic analysis of human gut microbiomes evolved in the absence of immunoglobulin A (IgA). We show that human IgA deficiency is not associated with massive quantitative perturbations of gut microbial ecology. While our study underlines a rather expected pathobiont expansion, we at the same time highlight a less expected depletion in some typically beneficial symbionts. We also show that IgM partially supply IgA deficiency, explaining the relatively mild clinical phenotype associated with the early steps of this condition. Microbiome studies in patients should consider potential issues such as cohort size, human genetic polymorphism and treatments. In this commentary, we discuss how such issues were taken into account in our own study.
在最近发表的一篇文章中,我们报告了在缺乏免疫球蛋白 A(IgA)的情况下人类肠道微生物组的宏基因组分析。我们表明,人类 IgA 缺乏症与肠道微生物生态的大量定量扰动无关。虽然我们的研究强调了一种相当预期的机会病原体扩张,但同时也突出了一些典型有益共生体的减少。我们还表明 IgM 部分补充了 IgA 缺乏症,这解释了与这种疾病早期阶段相关的相对较轻的临床表型。对患者的微生物组研究应考虑潜在问题,如队列规模、人类遗传多态性和治疗方法。在这篇评论中,我们讨论了我们自己的研究中是如何考虑这些问题的。